Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guan-Zhong Qiu

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Medicinal Research Reviews|October 25, 2016
Targeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and ChallengesWei-Lin Jin, Xiao-Yuan Mao, Guan-Zhong Qiu
Life Sciences|February 20, 2020
Hypoxia-induced USP22-BMI1 axis promotes the stemness and malignancy of glioma stem cells via regulation of HIF-1αGuan-Zhong Qiu, Qiang Liu, Xiao-Gang Wang, et al.
Pharmacology & Therapeutics|December 7, 2016
The bad seed gardener: Deubiquitinases in the cancer stem-cell signaling network and therapeutic resistanceGuan-Zhong Qiu, Wei Sun, Ming-Zhu Jin, et al.
Cancer Letters|November 28, 2017
Organoids: An intermediate modeling platform in precision oncologyMing-Zhu Jin, Run-Run Han, Guan-Zhong Qiu, et al.
Trends in Pharmacological Sciences|June 13, 2017
Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic StrategiesGuan-Zhong Qiu, Ming-Zhu Jin, Jin-Xiang Dai, et al.
Cancer Science|May 23, 2018
Ubiquitin-specific protease 22 acts as an oncoprotein to maintain glioma malignancy through deubiquitinating B cell-specific Moloney murine leukemia virus integration site 1 for stabilizationGuan-Zhong Qiu, Xiao-Yuan Mao, Yue Ma, et al.
Biomaterials|May 3, 2015
The transducible TAT-RIZ1-PR protein exerts histone methyltransferase activity and tumor-suppressive functions in human malignant meningiomasMao-Hua Ding, Zhen Wang, Lei Jiang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Medicinal Research Reviews|October 25, 2016
Targeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and ChallengesWei-Lin Jin, Xiao-Yuan Mao, Guan-Zhong Qiu
Life Sciences|February 20, 2020
Hypoxia-induced USP22-BMI1 axis promotes the stemness and malignancy of glioma stem cells via regulation of HIF-1αGuan-Zhong Qiu, Qiang Liu, Xiao-Gang Wang, et al.
Pharmacology & Therapeutics|December 7, 2016
The bad seed gardener: Deubiquitinases in the cancer stem-cell signaling network and therapeutic resistanceGuan-Zhong Qiu, Wei Sun, Ming-Zhu Jin, et al.
Cancer Letters|November 28, 2017
Organoids: An intermediate modeling platform in precision oncologyMing-Zhu Jin, Run-Run Han, Guan-Zhong Qiu, et al.
Trends in Pharmacological Sciences|June 13, 2017
Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic StrategiesGuan-Zhong Qiu, Ming-Zhu Jin, Jin-Xiang Dai, et al.
Cancer Science|May 23, 2018
Ubiquitin-specific protease 22 acts as an oncoprotein to maintain glioma malignancy through deubiquitinating B cell-specific Moloney murine leukemia virus integration site 1 for stabilizationGuan-Zhong Qiu, Xiao-Yuan Mao, Yue Ma, et al.
Biomaterials|May 3, 2015
The transducible TAT-RIZ1-PR protein exerts histone methyltransferase activity and tumor-suppressive functions in human malignant meningiomasMao-Hua Ding, Zhen Wang, Lei Jiang, et al.
Pageof 1